Scientists ‘disprove' one of Jesus Christ's best-known miracles as study claims it was just ‘a natural phenomenon'
Click to share on Facebook (Opens in new window)
A TEAM of scientists claims to have debunked one of Jesus Christ's most famous miracles — saying the Son of God may not have fed 5,000 people with just five loaves and two fish after all.
Instead, researchers believe it could have been a freak natural event in Israel's Lake Kinneret — known in the Bible as the Sea of Galilee — that brought a massive haul of fish to the surface for easy collection.
Sign up for Scottish Sun
newsletter
Sign up
4
Ghent – Crucifixion paint on the wood from side altar in underground chapel of st. Baaf's Cathedral from 16. cent. on June 23, 2012 in Gent, Belgium.
Credit: Getty
4
A vintage illustration of Jesus Christ, published in Germany, circa 1900. (Photo)
Credit: Getty - Contributor
The story of the 'Feeding of the 5,000' is told in all four Gospels, where Jesus is said to have blessed a small amount of food and miraculously distributed it to feed a vast crowd.
But in a 2024 study published in Water Resources Research, scientists monitored oxygen levels, water temperature, and wind speed across Lake Kinneret — and say they discovered evidence of sudden mass fish die-offs caused by unusual weather patterns.
Strong winds sweeping across the lake, they say, can churn the water and cause an 'upwelling' of cold, low-oxygen water from the bottom, which kills fish and sends them floating to the surface.
According to the researchers, to anyone watching from the shore, it would look like fish were suddenly appearing by the thousands — creating the illusion of a miracle and allowing them to 'be easily collected by a hungry populace'.
The team believes this could explain the Gospel passage where Jesus tells his disciples — after a fruitless night of fishing — to cast their nets on the other side of the boat, suddenly hauling in a bounty.
However, Biblical scholars aren't buying it.
Critics slammed the theory for missing the point entirely, pointing out that no fish were caught during the miracle of the loaves and fishes.
The article on AnsweringGenesis.org hit back, saying: 'Jesus simply took the five loaves and two fish, thanked God, broke the loaves, handed everything to his disciples, and the disciples handed the food out. No fish were caught!'
According to Matthew 14:13–21, Jesus 'saw a great crowd, and he had compassion on them and healed their sick.'
Brit shares 'proof' he's found Jesus's TOMB & Ark of the Covenant in cave
When his disciples told him to send the people away to find food, he replied: 'They need not go away; you give them something to eat.'
After blessing the five loaves and two fish, the Bible says: 'they all ate and were satisfied.
'And they took up 12 baskets full of the broken pieces left over.'
Despite the backlash, the researchers argue that understanding how fish may have mysteriously appeared in huge quantities doesn't take away from the spiritual message of the event — which many see as symbolic of generosity and faith.
Still, religious sceptics say the study adds weight to theories that Jesus' wonders may have had natural explanations — while believers insist some things just can't be explained away by science.
It comes after a stunning AI-generated video claims to reveal the true face of Jesus Christ — using images based on the mysterious Turin Shroud.
Believers say the Shroud of Turin was the burial cloth wrapped around Jesus after his crucifixion.
4
AI has created a video of Jesus Christ by feeding it the Turin Shroud
Credit: X
4
Christ can be seen smiling, blinking and praying in the video
Credit: X
Now, photos of the ancient linen have been processed through Midjourney, an AI image generator, to create a realistic image and video of Christ.
The video shows Jesus blinking, smiling, and praying — potentially as he did before his crucifixion around 33AD.
He appears with shoulder-length brown hair, a beard, brown eyes, a straight nose, and high cheekbones.
His skin tone is pale, which has sparked debate among academics and online.
Last year, The Sun also used AI to recreate the Son of God's appearance.
The Gencraft tool was fed the prompt 'face of Jesus based on the Shroud of Turin' and returned images of a man with hazel eyes, a gentle expression, a neat beard, clean eyebrows, and long brown hair.
Under his weary eyes, signs of exhaustion were visible.
Many researchers agree that the man wrapped in the Shroud appeared to be between 5ft 7in and 6ft tall, with sunken eyes and a full beard.
The markings on the cloth also show what some believe to be crucifixion wounds — including injuries to the head, shoulders, arms, and back, consistent with a thorn crown and Roman whips.
The Bible recounts that Jesus was scourged by Roman soldiers, crowned with thorns, and forced to carry his cross before dying in agony.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
6 hours ago
- Metro
Common drug may speed up ageing, study finds
Hiyah Zaidi Published July 17, 2025 10:27am Link is copied Comments Taking a common drug which acts on the nervous system could be leading to faster ageing in older adults, a new study says. Published in the journal JAMA Open Network, the researchers concluded that a high exposure to anticholinergic drugs - used in flu medicine, and to relieve motion sickness and histamine reactions - could lead to a faster decline in physical performance in older age (Picture: Getty) Anticholinergic drugs are also used to treat chronic obstructive pulmonary disease, bladder illnesses and Parkinson's. They work by blocking the action of the nerve-to-nerve signalling molecule acetylcholine, which plays a key role in the functioning of the nervous system. They affect several major bodily functions. However, by discontinuing use, the sedative and cognitive adverse effects can be reversed (Picture: Getty) Anticholinergics are common. They are used to reduce cold and flu symptoms, (diphenhydramine/Benadryl), relieve motion sickness and histamine reactions (promethazine/Phenergan) and relax the bladder to limit needing the toilet all the time (oxybutynin/Ditropan). They're also used to relieve muscle stiffness in Parkinson's disease sufferers and even used as a common sleep aid (Picture: Getty) Anticholinergics can be used to dull an important neurotransmitter for thinking, muscle control and memory, known as acetylcholine. But past studies have revealed that by dulling it, a person can experience confusion, drowsiness, dizziness and weakness, and over time, these symptoms can turn into chronic issues with memory and movement. The latest study wanted to look at the effects of constant exposure to the drugs over a decade – while looking at intensity, duration and timing of past intake (Picture: Getty) The researchers looked at the changes in walking speed and grip strength in over 4,000 older adults over time and compared this with their exposure to anticholinergic medications based on data collected from February 1994 to March 2020. Their study focused on older people, so the average baseline for the men and women was 74.3 years, with follow-up assessments around eight years later (Picture: Getty) They found that while grip strength appeared unaffected, a higher exposure to anticholinergics was linked to a greater decline in walking speed, especially in people who had taken these drugs in what would be deemed clinically conventional, so more than 1,096 daily doses over 10 years. Frailty and changes in balance and gait are linked to multiple measures of poor health outcomes, including disability and mortality. However, they also found that those who met that 1,096 daily-dose threshold in the previous six years were found to have a much higher likelihood of weakened grip as well as slower walking pace (Picture: Getty) The researchers do not advise steering clear of anticholinergics completely, but ask people to be mindful of long-term use. They said: 'Anticholinergics are associated with numerous adverse outcomes in older adults; therefore, it is essential for clinicians to avoid their use when possible, prescribe the lowest effective dose, and periodically reevaluate patients to identify de-prescribing opportunities to minimize potential harms' (Picture: Getty) Your free newsletter guide to the best London has on offer, from drinks deals to restaurant reviews.
Scottish Sun
12 hours ago
- Scottish Sun
Two NHS drugs slows and could REVERSE devastating Alzheimer's, ‘exciting' study finds
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) TWO NHS drugs could be combined to treat, and even reverse, the most common form of dementia, scientists claim. A pair of cancer drugs have been identified as a powerful duo that may tackle Alzheimer's disease, after scientists sifted through 1,300 approved medicines. Sign up for Scottish Sun newsletter Sign up 1 Alzheimer's was reversed in mice Credit: Alamy The American team used cutting-edge computer tools to match the gene changes seen in Alzheimer's patients with medicines that reverse those effects. They found that two cancer drugs, both already available on the NHS, reduced brain degeneration in mice with the disease, and even brought back their memory. The study, from the University of California, San Francisco (UCSF), first looked at how Alzheimer's alters the activity of individual brain cells. They then searched for existing drugs that trigger the opposite changes, with the aim of rewiring damaged neurons and brain cells called glia. And when they tested the top two candidates, letrozole and irinotecan, in lab mice, the results were impressive. One theory of how Alzheimer's comes about is that sticky proteins - like amyloid-beta - start clumping together in the brain years before symptoms appear. These toxic clumps block communication between brain cells and trigger inflammation, eventually causing the cells to die. Some scientists believe this buildup is the root cause of Alzheimer's, so clearing it could stop the disease in its tracks. When combined, the cancer drugs not only halted brain cell damage but also undid toxic clumps of proteins, restored memory and reversed the disease's genetic footprint. Prof Marina Sirota, senior author, said: 'We're excited that our computational approach led us to a potential combination therapy for Alzheimer's based on existing FDA-approved medications.' Common painkiller used for back pain ups risk of dementia by 29%, scientists warn She added: 'Alzheimer's disease comes with complex changes to the brain, which has made it tough to study and treat — but our tools opened up the possibility of tackling that complexity directly.' The scientists then trawled through the anonymised medical records of 1.4million over-65s and found those already taking the cancer drugs were less likely to develop Alzheimer's. Dr Yaqiao Li, the study's lead author, said: 'Thanks to all these existing data sources, we went from 1,300 drugs, to 86, to 10, to just five. 'In particular, the rich data collected by all the UC health centres pointed us straight to the most promising drugs. It's kind of like a mock clinical trial.' Letrozole is typically used to treat breast cancer, while irinotecan is prescribed for colon and lung cancer. Both are already used in the UK. 'So exciting' Prof Yadong Huang, co-senior author, said: 'Alzheimer's is likely the result of numerous alterations in many genes and proteins that, together, disrupt brain health. 'This makes it very challenging for drug development - which traditionally produces one drug for a single gene or protein that drives disease.' He added: 'It's so exciting to see the validation of the computational data in a widely used Alzheimer's mouse model.' The breakthrough, published in the journal Cell, could fast-track trials in humans. Prof Sirota said: 'If completely independent data sources, such as single-cell expression data and clinical records, guide us to the same pathways and the same drugs and then resolve Alzheimer's in a genetic model then maybe we're onto something.' She added: 'We're hopeful this can be swiftly translated into a real solution for millions of patients with Alzheimer's.' Alzheimer's causes a relentless decline in cognition, learning, and memory. But decades of research have only produced two FDA-approved drugs, neither of which can meaningfully slow the decline. In the UK, no disease-modifying drugs are currently approved or available. Instead, the UK relies on symptom-managing drugs, such as Donepezil and Rivastigmine.
Scottish Sun
14 hours ago
- Scottish Sun
Common sweetener in fizzy drinks and yoghurt ‘can kill off the deadliest cancer'
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A COMMON sugar substitute used in fizzy drinks, yoghurts and gum could be used to combat one of the deadliest kinds of cancer. Researchers fermented the zero calorie sweetener and tested it against pancreatic cancer - finding that it killed off malignant cells but didn't harm healthy ones. Sign up for Scottish Sun newsletter Sign up 2 Stevia extract could be used to help fight pancreatic cancer, researchers suggested Credit: Getty 2 They tested fermented extracts against pancreatic cancer cells in a lab dish Credit: Getty Stevia is a shrub-like herb used to sweeten drinks and desserts instead of sugar, which can also be bought as powder or tablets. Previous research has suggested that stevia leaf extracts could have potential "anticancer effects". But isolating specific substances within the herb that could help protect against cancer and using them has remained challenging. Researchers from Hiroshima University suggested fermenting stevia with bacteria can structurally change the extract and produce bioactive metabolites - compounds that can impact living organisms. Study author Masanori Sugiyama, a professor in the Department of Probiotic Science for Preventive Medicine, said fermentation - or "microbial bio-transformation" - could "enhance the pharmacological efficacy of natural plant extracts" like stevia. The team tested their theory out against pancreatic cancer cells. "Pancreatic cancer is a highly malignant tumour of the digestive system with a poor prognosis," co-author Prof Narandalai Danshiitsoodol said. "Globally, the incidence and mortality rates of pancreatic cancer continue to rise, with a five-year survival rate of less than 10 per cent. "The primary reason pancreatic cancer is considered one of the deadliest cancers is its subtle, insidious onset, with most patients being diagnosed at an advanced stage and missing the optimal treatment window. "Furthermore, pancreatic cancer is highly invasive and prone to metastasis, showing significant resistance to existing treatments such as surgery, radiotherapy, and chemotherapy, resulting in very limited therapeutic efficacy. The most common symptoms of pancreatic cancer - as patients share their stories "Therefore, there is an urgent need to identify new and effective anticancer compounds, particularly those derived from medicinal plants." Researchers used lactic acid bacteria to ferment stevia extracts. They isolated over 1200 strains from fruits, vegetables, flowers, and medicinal plants and evaluated their health benefits. They finally landed on Lactobacillus plantarum SN13T strain (FSLE) derived from banana leaves "to enhance the antioxidant and anticancer activities of stevia leaf extract through fermentation". They tested fermented and non-fermented stevia extracts against pancreatic cancer cells in lab dishes. Fermented stevia killed pancreatic cancer cells more efficiently than the non-fermented extract, the study published in the International Journal of Molecular Sciences found. This suggested that "the fermentation process enhances the bioactivity of the [stevia] extract", Prof Sugiyama said. Researchers tested out different fermentation levels to see which was most effective against cancer cells. Symptoms of pancreatic cancer PANCREATIC cancer doesn't always cause symptoms in its early stages. As the cancer grows and you do begin to show signs, these may come and go and be unspecific, making it hard to diagnose, according to Pancreatic Cancer UK. Common symptoms include: Indigestion - a painful, burning feeling in your chest with an unpleasant taste in your mouth Tummy or back pain - it may start as general discomfort or tenderness in the tummy area and spread to the back, which get worse lying down and feel better is you sit forward Diarrhoea and constipation - see a GP if you have runny poos for more than seven days, especially if you've lost weight as well Steatorrhoea - pale, oily poo that's bulky, smells horrible and floats, making it hard to flush Losing a lot of weight without meaning to Jaundice - yellow skin and eyes, as well as dark pee, pale poo and itchy skin Lower concentrations didn't kill cancer cells immediately, but they slowed their growth. Healthy kidney cells were mostly unaffected by the stevia extracts. Researchers plan to study how fermented stevia affects cancer in mice next, to see how various dosages will work in living organisms. 'The present study has substantially enhanced our understanding of the mechanism of action of the Lactobacillus plantarum SN13T strain in the fermentation of herbal extracts, while also offering a valuable research perspective on the potential application of probiotics as natural anti-tumour agents,' Prof Danshiitsoodol said. In the UK, about 10,800 people are diagnosed with pancreatic cancer each year and 9,600 pass away from it, according to Cancer Research UK. It's the fifth most common cause of cancer death. Since the early 1990s, pancreatic cancer incidence rates have increased by 18 per cent in the UK. The disease is often diagnosed at a late stage because it frequently lacks noticeable symptoms in the early stages. Surgery, chemotherapy and radiation can help extend patients' lives. A blood test to pick up early signs of pancreatic cancer is being trialled in patients with a recent diagnosis of type 2 diabetes - a known risk factor for the disease. Meanwhile, researchers at Case Western Reserve University and Cleveland Clinic have developed a new type of jab to fight pancreatic cancer.
